![]() | |
Clinical data | |
---|---|
Other names | LSM-775, N-Morpholinyllysergamide, Lysergic acid morpholide |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | hepatic |
Excretion | renal |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H23N3O2 |
Molar mass | 337.423 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
N-Morpholinyllysergamide (LSM-775) is a derivative of ergine.[2] It is less potent than LSD but is reported to have some LSD-like effects at doses ranging from 75 to 700 micrograms and a shorter duration. There are fewer signs of cardiovascular stimulation and peripheral toxicity with LSM-775 compared to LSD.[3][dubious – discuss]